A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Conditions

• HIV Infections
• Tuberculosis

Interventions

• DRUG: Cycloserine
• DRUG: Ethionamide
• DRUG: Capreomycin sulfate
• DRUG: Aminosalicylic acid
• DRUG: Streptomycin sulfate
• DRUG: Ethambutol hydrochloride
• DRUG: Amikacin sulfate
• DRUG: Isoniazid
• DRUG: Pyrazinamide
• DRUG: Pyridoxine hydrochloride
• DRUG: Levofloxacin
• DRUG: Rifampin
• DRUG: Clofazimine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)